United States · FDA National Drug Code directory

BHI Skin

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
62795-1016_29e7a2ad-a3bb-4527-a81d-0c6b4dba65a5
Product NDC
62795-1016
Form
TABLET
Composition / generic term
BERBERIS VULGARIS ROOT BARK, GRAPHITE, HYDROFLUORIC ACID, LYCOPODIUM CLAVATUM SPORE, PETROLATUM, TOXICODENDRON PUBESCENS LEAF, SEPIA OFFICINALIS JUICE, and SULFUR
Labeler
MediNatura Inc
Marketing category
UNAPPROVED HOMEOPATHIC
Marketing start / end (source format)
20150101
Source listing expiry
20261231

Source-listed ingredients

  • BERBERIS VULGARIS ROOT BARK — 6 [hp_X]/1
  • GRAPHITE — 10 [hp_X]/1
  • HYDROFLUORIC ACID — 10 [hp_X]/1
  • LYCOPODIUM CLAVATUM SPORE — 12 [hp_X]/1
  • PETROLATUM — 10 [hp_X]/1
  • TOXICODENDRON PUBESCENS LEAF — 8 [hp_X]/1
  • SEPIA OFFICINALIS JUICE — 10 [hp_X]/1
  • SULFUR — 12 [hp_X]/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 1 PACKAGE in 1 CARTON (62795-1016-3) / 100 TABLET in 1 PACKAGE · 62795-1016-3

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →
BHI Skin — United States | Molindra Medicines